Cardiac hypertrophy is an independent risk factor predictive of cardiovascular disease and is significantly associated with morbidity and mortality. The mechanism by which angiotensin II (Ang II) and dietary sodium exert additive effects on the development of cardiac hypertrophy is unclear. The goal of this study was to evaluate the hypothesis that, where there is a genetic predisposition to Ang IIdependent hypertrophy, there is also an increased susceptibility to sodium-induced hypertrophy mediated by AT 1 -receptor expression.
Introduction
Cardiac hypertrophy is an independent risk factor predictive of cardiovascular disease and is significantly associated with morbidity and mortality. 1 Haemodynamic loading is a common antecedent of the development of hypertrophy, 2 but elevated angiotensin II (Ang II) and dietary sodium intake have both been linked with the development of cardiac hypertrophy independently of blood pressure (BP). 3, 4 The role of Ang II as a direct-acting growth promotor in the heart is now well established. In normotensive humans, plasma Ang II levels are correlated with cardiac size. 5 Clinically, there is evidence that cardiac hypertrophy in hypertensives is most effectively regressed by therapies involving blockade of Ang II production or receptors. 6, 7 Experimentally, Ang II is well characterised as an in vitro cardiac trophic agent. 8 When administered systemically at subpressor doses, Ang II induces myocardial growth. 9, 10 Cardiac-specific overexpression of Ang II in a transgenic murine model is associated with cardiac hypertrophy in the absence of hypertension. 11 An elevated dietary sodium intake has also been implicated in the development of cardiac hypertrophy. In adolescents and also in more mature untreated normotensives and hypertensives, an association has been demonstrated between urinary sodium excretion (as a measure of sodium intake) and left ventricular mass index. 12, 13 Experimental studies have similarly established that high dietary sodium intake induces cardiac remodelling associated with elevated cardiac weight index and concentric hypertrophy in normotensive and hypertensive rats. 14, 15 A significant interaction can be demonstrated between Ang II and dietary sodium intake in the induction and regression of hypertrophy in various experimental settings. Cardiac hypertrophy induced by Ang II infusion is greatest in rats fed a high sodium diet, even when there is no significant effect on BP. 16 
can be observed in various reno-vascular models of hypertension, in some instances independent of a BP effect. 17 The beneficial cardiovascular effects of angiotensin-converting enzyme (ACE) inhibition can be antagonised by high sodium intake. 18, 19 Conversely, a high sodium intake may protect against the cardiac atrophy and functional deterioration seen under conditions of aggressive systemic blockade of the renin angiotensin system (RAS). 20, 21 The mechanism by which Ang II and dietary sodium exert additive effects on the development of cardiac hypertrophy is unclear. 4, 20, 22 The interaction seems somewhat paradoxical, as elevated sodium intake is known to down-regulate the activity of the systemic RAS, via suppression of renin secretion. 23, 24 Interestingly, clinical studies have shown that inadequate suppression of plasma Ang II levels in response to high dietary sodium intake may exacerbate left ventricular hypertrophy in mild hypertensives. 25 There is experimental evidence that when the systemic RAS is down-regulated, an up-regulation in the expression of Ang II AT 1 -receptors occurs. AT 1 -receptor up-regulation has been observed in cardiac, vascular and renal tissues in association with elevated dietary sodium intake. 26, 27 The AT 1receptor is involved in hypertrophic signalling, 8 and it is possible that, even when Ang II production is systemically reduced, a rebound overexpression of these receptors may promote cellular growth in some tissues.Whether this alteration in receptor expression occurs independently of haemodynamic influence has yet to be established.
The goal of this study was to determine whether cardiac-derived Ang II and dietary sodium could exert a combined influence on the promotion of cardiac hypertrophy. Specifically, the question of whether a local elevation in cardiac Ang II, in the absence of disturbance of the systemic RAS, is able to synergise with elevated dietary sodium to exacerbate hypertrophy was addressed. Diets of low-and high-sodium content were fed to control and transgenic mice which exhibit cardiac specific overexpression of angiotensinogen. 11 These mice present concentric cardiac hypertrophy, in the absence of hypertension and fibrosis. 28, 29 The effects of altered sodium intake on cardiac growth and AT 1 -receptor expression was investigated to evaluate the hypothesis that, where there is a genetic predisposition to hypertrophy, there is also an increased susceptibility to sodium-induced hypertrophy mediated by AT 1 -receptor expression.
Materials and methods

Animals and treatments
Experiments were conducted following the recommendations of the Australian Code of Practice for the Care and Use of Animals Scientific Purposes and with the approval of the University of Melbourne Animal Experimentation Ethics Committee. Transgenic (TG) and wild-type (WT) littermate control mice were obtained from the breeding colony in the Biological Research Facility (Faculty of Medicine, University of Melbourne) established from Angiotensinogen transgenic (TG1306/1R) founders imported from Lausanne. 11 TG1306/1R mice were originally generated by inserting a high copy number of the rat angiotensinogen transgene into the mouse genome under the control of a α-myosin heavy chain (α-MHC) promoter. 11 Adult male TG and WT mice (n=9 and 11 TG and WT per group, mean age 24.5+0.9 weeks) were divided into treatment groups matched for age and body weight. The mice were monitored on standard chow for one week prior to allocation to a high-or low-sodium diet for a 40-day treatment period. The diets were identical (based on the American Institute of Nutrition AIN93 rodent diet), containing all essential vitamins and minerals, with the modification that the high sodium diet contained 4% w/w NaCl (HS) and the low sodium diet contained 0.3% w/w NaCl (LS). Supplied diets were frozen at -20ºC until required (Smart Foods Centre, University of Wollongong, Wollongong, Australia). During treatment, animal weights were checked weekly and the animals monitored to ensure maintenance of normal somatic growth.
Tissue collection
At the conclusion of the dietary intervention period, mice were anaesthetised by intra-peritoneal (i.p.) injection of pentobarbitone sodium, 70 mg/kg (Nembutal). The hearts were excised and palpitated in 0.9% saline to remove any blood remaining in the ventricles, before being blotdried and weighed. Atria were dissected away from the ventricles. The atrial weights and the combined weight of the two ventricles were measured. Heart weights were divided by mouse body weights to calculate weight indices, to normalise for differences in body size.Tissues were immediately frozen in liquid nitrogen and stored at -80ºC.
RT-PCR
AT 1Aand AT 2 -receptor mRNA levels in ventricular tissues (combined right and left) were assessed using RT-PCR. Co-amplification of GAPDH was used as an internal control for normalisation. Frozen tissues were homogenised using the Polytron ® PT 3100 (Kinematica AG).Total RNA was extracted using TRIzol reagent (Invitrogen). Primers and PCR cycling conditions were optimised. All reagents were obtained from Roche, except the 50 bp DNA ladder (Fermentas). AT 1A , AT 2 -receptors and GAPDH primers were designed using GenBank. GenBank accession numbers are GI 31341112, GI 31982509 and GI 20832384 respectively. AT 1A sense: 5` GCTTGCTGGCAATG- . Expected DNA fragment size was calculated using a least square fit to the reciprocal relationship between mobility and fragment size when run on a 1% agarose gel with 50bp DNA ladder for reference. RT-PCR was performed using the SuperScript™ III First-Strand Synthesis System for RT-PCR (Invitrogen) and run in the TGradient 96 Thermocycler (Biometra ® ). Reverse transcription ran for a single cycle: denaturation, 65ºC for five minutes, annealing, 25ºC for 10 minutes; reverse transcription, 50ºC for 50 minutes; and reaction termination, 85ºC for five minutes. Negative RT controls were run omitting reverse transcriptase. cDNA was stored at 4ºC until PCR.An initial cycle of 95ºC for five minutes was included. Optimal duplex amplification of DNA using the primers above (with nucleotide excess) was found to occur at 31 cycles under the following conditions: denaturation, 94ºC for one minute; annealing, 58ºC for one minute; and extension, 72ºC for one minute 15 seconds. On the final cycle, an elongation step of 72ºC for 10 minutes was also included.
PCR products were separated on 1% agarose gels containing ethidium bromide, and visualised using UV illumination. Gel images were captured using a low light level digital camera with emission specific filters, and stored using a Kodak I.D. imaging system (V3.5). Bands were densitometrically analysed using Image J (V1.27). Product yield was determined in arbitrary units by subtracting the background light signal from the DNA band, and computing the mean pixel intensity in the region of interest.The product yield for AT 1Aand for AT 2 -receptors was normalised using same-tube GAPDH signal by calculating the ratio of the values determined for each of these bands (AT 1A /GAPDH and AT 2 /GAPDH).
Statistical analysis
Data were analysed by two-way analysis of vari-ance (MINITAB,V 13.1). Post-hoc analysis was performed by Tukey HSD. All data are expressed as mean + SEM. p<0.05 was considered significant.
Results
Animal growth and heart growth
Wild-type (WT) and transgenic (TG) mice fed a high-or reduced-sodium diet exhibited a modest and comparable weight gain over the 40-day diet treatment period, as would be expected of mice at a relatively mature stage of development ( Figure  1 ). In the seven-day period immediately following the introduction of the diet treatments, some animals recorded slightly reduced food intake during the diet 'familiarisation' process, but feeding behaviour stabilised after this period. No significant differences in the mean body weights of the groups were detected at the commencement or conclusion of the treatment period.
The heart weight of TG mice was significantly higher than that of WT mice for both diet treatment groups. As shown in Figure 2 (panel A), with LS diet treatment, the TG mice exhibited an increase in heart weight of about 23% relative to WT, with this genotype difference was more accentuated in the HS diet treatment group. Diet treatment per se, was not identified as a significant influence on heart size in this analysis.When heart size was normalised for body size (Figure 2, yielding significant genotype and genotype/diet interaction effects. Overall, the normalised heart weights of the TG mice were elevated compared with WT rats and, in addition, the extent of the increase was greater for mice maintained on the HS diet treatments. Compared to WT, the TG exhibited a 41% increase in cardiac weight index when treated with HS diet. In contrast, the TG cardiac weight index increase (12%) was more modest for animals maintained on LS diet. The pattern of changes in ventricular weights and in ventricular weight indices ( Figure 3 ) reflected those seen for the whole heart. For the TG mice, regardless of diet, both ventricular weight parameters were elevated compared to WT. No significant general effect of diet was detected, but a selective effect of the HS diet on the degree of ventricular hypertrophy in the TG was observed when assessing the normalised ventricular weight (Figure 3, panel B) .TG ventricular weight index was 37% higher than WT for the HS treatment, compared to the lesser increase of 13% seen for animals receiving the LS treatment.
Interestingly, evaluation of the atrial weight parameters (both normalised and non-normalised, Figure 4 ) revealed a significant effect of dietary sodium level on tissue weight, independent of animal genetic type. That is, a HS diet was associated with an increase in atrial weight for both the WT (21%) and the TG (33%) mice, relative to values measured for LS treated groups.This was superimposed on the underlying significant difference in atrial weights seen overall in the TG compared with WT (panel A). For atrial weight index (panel B), a more specific genotype-diet interaction was identified statistically, with the TG exhibiting a more marked elevation in normalised tissue weight in response to HS diet than the WT (38% vs. 12% increases respectively).
Angiotensin receptor expression
The relative expression levels of the AT 1Aand AT 2receptor subtypes, normalised to the co-expression of GAPDH, are shown in Figure 5 (Panels A &  B) .These data exhibited a high degree of variability, suggesting considerable tissue-to-tissue variation in receptor expression profile. No overall differences in receptor sub-type expression levels were detected between WT and TG. Moreover, there was no evidence of a systematic effect of diet treatment on the expression of either receptor subtype. Although there was a tendency for AT 1A -receptor suppression with HS dietary treatment, and a reciprocal tendency for AT 2 expression elevation, a comparison of the ratio of these receptor expression levels (AT 1A /AT 2 ) failed to demonstrate a significant shift ( Figure 5 Panel C). Thus, neither diet treatment nor mouse genetic background could be associated with a regulatory alteration in Ang II receptor expression. 
Discussion
This study demonstrates that, where there is a preexisting genetic condition of Ang II-dependent cardiac hypertrophy, the pro-growth effect of elevated dietary sodium intake is selectively augmented. In TG and WT mice treated with either a low (0.3%) or high (4.0%) sodium diet, this effect was evident after a relatively short dietary treatment intervention (40 days). Evaluation of the levels of Ang II receptor mRNA further demonstrated that this differential growth response was not associated with an altered relative expression of either AT 1Aor AT 2 -receptor subtypes. The transgenic mouse model used in this study exhibits an elevation of cardiac Ang II, without spillover to the systemic circulation, and displays cardiac hypertrophy in the absence of hypertension. Plasma sodium levels in WT and TG fed a normal chow diet (sodium content usually ranging from 0.6-1.0%) are not different (WT 152.6+2.1 vs. TG 151.8+1.6 mmol/L, n=12). The degree of hypertrophy evident in TG mice fed the reduced sodium diet in this study is slightly lower than that previously reported for these animals maintained on normal chow. 11, 28 This suggests that hypertrophic growth may be modestly suppressed when dietary sodium is reduced, even at relatively modest levels of intake. For comparison, in humans a normal ad libitum sodium intake is commonly about 0.5% (2.9 mmol/kg/day) and a sodium-restricted diet can achieve an intake of about 0.1% (0.7 mmol/kg/day). 30 The HS diet treatment employed in this study represents an extreme elevation of sodium intake, and provides an enhanced contrast for experimental purposes.
The hypertrophic influence of elevated dietary sodium intake was found to be exacerbated in the TG.This observation confirms and extends earlier findings that the pro-growth effects of systemic Ang II and dietary sodium are additive. 16 In the present study we demonstrate that these trophic influences are synergistic even when the Ang II elevation is localised to the heart and not associated with alterations to the systemic RAS. Although BP was not monitored in this study, it is unlikely that the TG selective effect of increased heart size associated with elevated sodium intake could be attributed to a differential haemodynamic response in WT and TG mice. Previous studies have shown that these mice exhibit similar BP responses when treated with an AT 1 antagonist. 28 The presence of significant atrial hypertrophy also indicates that the cardiac growth is not due to altered systemic afterload conditions. Indeed, the finding that atrial weight was significantly influenced by dietary treatment, independent of animal genetic type, suggests that growth of this tissue may be subject to enhanced natriuresis-related trophic modulation. Expression levels of atrial natriuretic factor are increased in the TG heart. 11 No up-regulation of AT 1A -receptor expression was observed in association with the augmented cardiac growth in the TG. It has been previously shown in rats that an elevated sodium intake is associated with increased relative expression of cardiac AT 1 -receptors. 26 In the rat study, the dietary intervention was more dramatic (0.8% and 8.0% sodium levels were compared), and the receptor up-regulation was hypertension-dependent. In the TG, the locally elevated levels of Ang II in the heart could be expected to exert a down-regulatory effect on AT 1A expression. 31 This local effect would likely counteract a sodium-dependent systemic influence which might otherwise prevail, producing the observed net result that receptor mRNA levels are unaltered. The present study also found no evidence of altered AT 2 expression in WT or TG under either dietary regime and this is consistent with the findings of Zhu et al. (2004) . 26 In interpreting the findings related to receptor mRNA evaluation, caution is necessary, as expression shifts at the translational level and post-receptor signalling modulation effects cannot be excluded.
In the absence of a receptor regulatory response, the mechanisms involved in the combined effects of Ang II and elevated dietary sodium on hypertrophy induction require further elucidation.A possible involvement of sodium-dependent sympathetic activation has been proposed 4 but subsequent investigations have shown that adrenergic blockade fails to suppress the cardiac hypertrophy induced by a high-sodium diet. 32 An increased cardiomyocyte Na + flux has also been invoked as a possible mechanism by which elevated sodium intake may be linked with cardiomyocyte hypertrophic growth. 4 Increased activation of the cardiomyocyte Na + /H + exchanger has been observed with Ang II-induced hypertrophy, 33 and the coupling of proton export with Na + /Ca ++ exchange-mediated Ca ++ influx is well documented. Both enhanced alkalinity and elevated cytosolic Ca ++ are recognised cardiomyocyte growth induction signals. 34 However, a difficulty with this proposal is that, although in vitro studies suggest that elevated extracellular Na + modulates cardiomyocyte growth, 35 there is only limited evidence that serum Na + levels and cellular Na + fluxes are influenced by altered dietary Na + intake. 36, 37 Most recently, an additional link between dietary sodium intake, angiotensin and the generation of reactive oxygen species has been identified. Reactive oxygen species have been shown to mediate myocardial and vascular hypertrophic growth, and sodium restriction is associated with reduced production of these species. 38, 39 Further mechanistic studies are required to directly evaluate how altered sodium intake interacts with Ang II signalling to modify cardiomyocyte growth responses. 
